patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · antibody
nivolumab
Marketedupdated 2mo agoby Bristol-Myers Squibb Co🔗 ChEMBL
Approvedannual revenue · 2024–2024peak $9.3B
community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 15 approved and 112 investigational indications.
indications
investigational
NSCLCProstate CancerColorectal CancerMelanomaDLBCL
targets
Programmed cell death protein 1
all catalysts(86)
approval · 83
phase 1 2 completion · 1
phase 1 initiation · 1
phase 2 completion · 1
comments(0)
5-min edit window · permanent after that